In conclusion, our study provides pivotal insights into trajectories from CHIP to more advanced disease stages, highlighting the intermediate step of cytopenia as a crucial marker in the trajectory from CH to MN. This evidence concerns the gene STUB1 and cyclic hematopoiesis.